Ameriprise’s Verona Pharma VRNA Stock Holding History

Ameriprise’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-95,539	Closed	-$10.2M	–	4223
2025 Q3	$10.2M	Sell	95,539 -19,238	-17%	-$2.01M	﹤0.01%	1892
2025 Q2	$10.9M	Sell	114,777 -15,642	-12%	-$1.16M	﹤0.01%	1753
2025 Q1	$8.28M	Buy	130,419 +13,319	+11%	+$797K	﹤0.01%	1909
2024 Q4	$5.44M	Buy	+117,100	New	+$4.4M	﹤0.01%	2298
2024 Q3	–	Sell	-13,159	Closed	-$190K	–	4022
2024 Q2	$190K	Buy	+13,159	New	+$192K	﹤0.01%	3698

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Ameriprise's VRNA Position: Q4 2025 in Review

Ameriprise sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 95,539 shares — an estimated $10.2M sold.

Ameriprise first reported a position in VRNA in Q2 2024 and held it in 5 quarters. The position peaked at $10.9M in Q2 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Ameriprise reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Ameriprise sold 95,539 Verona Pharma shares in Q4 2025, an estimated $10.2M.
Ameriprise first reported a position in Verona Pharma in Q2 2024 and held it in 5 quarters.
Ameriprise's Verona Pharma position peaked at $10.9M in Q2 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Ameriprise's 13F filing for Q4 2025, filed 17 Feb 2026.